IC
BHVN icon

Ikarian Capital’s Biohaven BHVN Stock Holding History

Ikarian Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-325,600
Closed -$16.3M – 180
2024
Q3 		$16.3M Buy
+325,600
New +$12.7M 2.27% 8

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's BHVN Position: Q1 2026 in Review

Ikarian Capital increased its Biohaven (BHVN) stake by 94% in Q1 2026, buying an estimated $2.19M and bringing the position to 412,481 shares worth $3.49M. The position accounts for 0.28% of the portfolio, ranked #77.

Ikarian Capital first reported a position in BHVN in Q4 2022 and has held it in 6 quarters since. The position peaked at $11.6M in Q4 2022. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • Ikarian Capital held 412,481 shares of Biohaven worth $3.49M as of Q1 2026.
  • Ikarian Capital bought 200,000 Biohaven shares in Q1 2026, an estimated $2.19M.
  • Biohaven made up 0.28% of Ikarian Capital's portfolio in Q1 2026, its #77 holding.
  • Ikarian Capital first reported a position in Biohaven in Q4 2022 and has held it in 6 quarters since.
  • Ikarian Capital's Biohaven position peaked at $11.6M in Q4 2022.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.